PDS Biotechnology Corp logo

PDS Biotechnology Corp

NAS:PDSB (USA)  
$ 3.84 -0.63 (-14.06%) 11:09 PM EST
At Loss
P/B:
4.87
Market Cap:
$ 119.30M
Enterprise V:
$ 108.72M
Volume:
4.34M
Avg Vol (2M):
805.96K
Also Trade In:
Volume:
4.34M
At Loss
Avg Vol (2M):
805.96K

Business Description

Description
PDS Biotechnology Corp operates as a clinical-stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
Name Current Vs Industry Vs History
Cash-To-Debt 2.3
Equity-to-Asset 0.43
Debt-to-Equity 0.96
Debt-to-EBITDA -0.49
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 15.07
9-Day RSI 23.75
14-Day RSI 30.5
6-1 Month Momentum % 19.61
12-1 Month Momentum % 7.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.21
Quick Ratio 6.21
Cash Ratio 5.93

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -78.8
Shareholder Yield % -15.63

Financials (Next Earnings Date:2024-05-15 Est.)

PDSB's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PDSB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

PDS Biotechnology Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.71
Beta 1.49
Volatility % 92.84
14-Day RSI 30.5
14-Day ATR ($) 0.406033
20-Day SMA ($) 5.1645
12-1 Month Momentum % 7.39
52-Week Range ($) 3.61 - 10.27
Shares Outstanding (Mil) 31.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PDS Biotechnology Corp Filings

Filing Date Document Date Form
No Filing Data

PDS Biotechnology Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

PDS Biotechnology Corp Frequently Asked Questions

What is PDS Biotechnology Corp(PDSB)'s stock price today?
The current price of PDSB is $3.84. The 52 week high of PDSB is $10.27 and 52 week low is $3.61.
When is next earnings date of PDS Biotechnology Corp(PDSB)?
The next earnings date of PDS Biotechnology Corp(PDSB) is 2024-05-15 Est..
Does PDS Biotechnology Corp(PDSB) pay dividends? If so, how much?
PDS Biotechnology Corp(PDSB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1